LivaNova PLC (NASDAQ:LIVN) Position Boosted by Victory Capital Management Inc.

Victory Capital Management Inc. increased its position in LivaNova PLC (NASDAQ:LIVN - Free Report) by 16.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 935,102 shares of the company's stock after buying an additional 133,401 shares during the period. Victory Capital Management Inc. owned about 1.72% of LivaNova worth $49,130,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of LIVN. Primecap Management Co. CA grew its holdings in LivaNova by 0.7% in the second quarter. Primecap Management Co. CA now owns 5,981,200 shares of the company's stock valued at $327,889,000 after purchasing an additional 44,049 shares during the period. Vanguard Group Inc. increased its holdings in shares of LivaNova by 3.5% during the 1st quarter. Vanguard Group Inc. now owns 1,832,987 shares of the company's stock worth $102,537,000 after buying an additional 62,480 shares during the last quarter. Point72 Asset Management L.P. raised its position in shares of LivaNova by 204.3% in the 2nd quarter. Point72 Asset Management L.P. now owns 1,285,636 shares of the company's stock worth $70,479,000 after buying an additional 863,157 shares during the period. Magnetar Financial LLC boosted its holdings in LivaNova by 8.1% in the second quarter. Magnetar Financial LLC now owns 814,452 shares of the company's stock valued at $44,648,000 after acquiring an additional 61,114 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC boosted its holdings in LivaNova by 3.3% in the third quarter. Allspring Global Investments Holdings LLC now owns 797,284 shares of the company's stock valued at $41,889,000 after acquiring an additional 25,277 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

LivaNova Stock Down 0.4 %

Shares of NASDAQ LIVN traded down $0.22 during midday trading on Friday, reaching $52.10. 357,203 shares of the company's stock were exchanged, compared to its average volume of 618,280. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.87 and a current ratio of 3.37. LivaNova PLC has a 52-week low of $42.75 and a 52-week high of $64.47. The business's fifty day moving average price is $51.77 and its two-hundred day moving average price is $52.95. The stock has a market capitalization of $2.83 billion, a PE ratio of 124.05 and a beta of 1.01.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on LIVN. Robert W. Baird raised their price objective on LivaNova from $66.00 to $72.00 and gave the stock an "outperform" rating in a report on Thursday, October 31st. Baird R W raised shares of LivaNova from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, September 17th. Needham & Company LLC reiterated a "buy" rating and set a $75.00 price objective on shares of LivaNova in a research note on Tuesday. StockNews.com downgraded shares of LivaNova from a "strong-buy" rating to a "buy" rating in a research note on Saturday. Finally, Stifel Nicolaus lifted their target price on shares of LivaNova from $70.00 to $72.00 and gave the company a "buy" rating in a report on Thursday, July 25th. One analyst has rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Buy" and an average target price of $69.17.

LivaNova Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.